T1bN0M0 thoracic esophageal squamous cell carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with T1bN0M0 TESCC treated with CRT at our institute from 2004 to 2017
Exclusion criteria
Exclusion criteria: Patients who do not meet the following criteria. (1) younger than 83 years old, (2) histologically proven squamous cell carcinoma, (3) primary tumor site in the thoracic esophagus, (4)depth of tumor invasion was diagnosed clinically or pathologically T1b, (5) no clinical evidence of lymph node or distant metastasis, (6) no prior chemotherapy and/or radiotherapy for esophagus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The results of 5-year local recurrence-free survival rate after chemoradiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| The results of 5-year overall survival rate and 5-year organ conserving survival rate after chemoradiotherapy. Acute and late adverse event | — |
Countries
Japan
Contacts
Keiyukai Sapporo Hospital Department of Radiation Oncology